TrialJournal of gynecologic oncology2024

QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.

Cheng Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.